DCDCA of 1993 amends DEA's chemical
recordkeeping and reporting requirements to remove the exemption
for certain drugs which contain ephedrine. CMCA of 1996 removed the
exemption for combination ephedrine, pseudoephedrine and
phenylpropanolamine drug products. Persons who previously were not
required to keep records or make reports regarding sales of the
products now must do so.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.